Detalhe da pesquisa
1.
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 33-43, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838010
2.
Observational study of HR+/HER2- metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS).
Clin Transl Oncol
; 25(10): 2950-2959, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029241
3.
Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial.
Eur J Cancer
; 174: 232-242, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36067616
4.
Neoadjuvant Model as a Platform for Research in Breast Cancer and Novel Targets under Development in this Field.
Breast Care (Basel)
; 13(4): 251-262, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30319327
5.
HER2-positive breast cancer: Current and new therapeutic strategies.
Breast
; 39: 80-88, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29631097
6.
Treatment of mild asymptomatic cardiotoxicity in early-stage HER 2-positive breast cancer. Is it justified?
Rev Esp Cardiol (Engl Ed)
; 76(6): 480-483, 2023 06.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36805384
7.
Observational study of HR+/HER2− metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS)
Clin. transl. oncol. (Print)
; 25(10): 2950-2959, oct. 2023. tab, graf
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-225076
8.
MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC).
Oncotarget
; 6(18): 16215-26, 2015 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26041880